Notice of Availability of Administrative Supplements to IDeA-CTR U54 Awards to Address the Opioid Crisis

Notice Number: NOT-GM-18-027

Key Dates
Release Date: April 12, 2018

Related Announcements

Issued by
National Institute of General Medical Sciences (NIGMS)


The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to NIGMS-funded U54 Institutional Development Award Program Infrastructure for Clinical and Translational Research (IDeA-CTR) awards. These funds are intended for existing IDeA-CTRs to allow them to expand and/or develop a focus on opioid addiction. Requests can be no more than $200,000 in direct costs exclusive of Facilities and Administrative costs on sub-contracts. Requests may be for one year of support only. Only one supplement request per IDeA-CTR will be accepted.
The NIGMS will supplement existing IDeA-CTR awards to develop new and/or expand ongoing pilot projects to address the opioid epidemic in rural and underserved communities in one or more of the following areas: treatment for opioid use disorder, prevention, recovery/rehabilitation, and pain management. The supplement will support multi-disciplinary approaches (including scientists, practitioners, community and local government), and community engagement projects to address the opioid crisis.
Applications should include a strong scientific justification for the requested supplement. As part of the budgetary justification, a statement regarding the expenditure of currently available unobligated grant funds should be included.
Applications must be submitted to PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin. Supp. Clinical Trial Optional)" by May 31, 2018.
Eligible investigators are strongly encouraged to discuss potential requests with their program directors before submitting applications.


Please direct all inquiries to:

Irina Krasnova, PhD
National Institute of General Medical Sciences (NIGMS)
Telephone: 301-827-7323